YungShin Global Holding Corporation (TPE:3705)

Market Cap	15.08B +3.7%
Revenue (ttm)	7.84B -8.4%
Net Income	896.24M -9.1%
EPS	3.36 -9.1%
Shares Out	266.36M
PE Ratio	16.82
Forward PE	n/a
Dividend	3.00 (5.31%)
Ex-Dividend Date	Jun 24, 2026

Volume	83,033
Open	56.80
Previous Close	56.60
Day's Range	56.20 - 56.80
52-Week Range	51.90 - 59.60
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2025, YungShin Global Holding's revenue was 8.38 billion, an increase of 4.28% compared to the previous year's 8.03 billion. Earnings were 880.82 million, a decrease of -24.62%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error